DMARD, TNF-inhibitor, Rheumatoid Arthritis, discontinuation of treatment, cost-effectiveness analysis, patient reported outcomes
J.M.W. Hazes (Mieke) , A.H.M. van der Helm-van Mil (Annette) , A.E.A.M. Weel (Angelique)
Erasmus University Rotterdam
hdl.handle.net/1765/135345
Rheumatology

van Mulligen, E. (2021, March 2). Different Viewpoints on Tapering DMARDs in Rheumatoid Arthritis. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/135345